| Product NDC: | 13537-432 |
| Proprietary Name: | CYZONE |
| Non Proprietary Name: | Octinoxate and Oxybenzone |
| Active Ingredient(s): | .07; .025 g/g; g/g & nbsp; Octinoxate and Oxybenzone |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 13537-432 |
| Labeler Name: | Ventura Corporation LTD. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part352 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20120713 |
| Package NDC: | 13537-432-01 |
| Package Description: | 4 g in 1 TUBE, WITH APPLICATOR (13537-432-01) |
| NDC Code | 13537-432-01 |
| Proprietary Name | CYZONE |
| Package Description | 4 g in 1 TUBE, WITH APPLICATOR (13537-432-01) |
| Product NDC | 13537-432 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Octinoxate and Oxybenzone |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20120713 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Ventura Corporation LTD. |
| Substance Name | OCTINOXATE; OXYBENZONE |
| Strength Number | .07; .025 |
| Strength Unit | g/g; g/g |
| Pharmaceutical Classes |